biote Corp. (BTMD)

NASDAQ: BTMD · Real-Time Price · USD
3.390
-0.280 (-7.63%)
At close: Mar 28, 2025, 4:00 PM
3.432
+0.042 (1.22%)
After-hours: Mar 28, 2025, 4:38 PM EDT
-7.63%
Market Cap 124.44M
Revenue (ttm) 197.19M
Net Income (ttm) 3.16M
Shares Out 36.71M
EPS (ttm) 0.09
PE Ratio 37.67
Forward PE 8.48
Dividend n/a
Ex-Dividend Date n/a
Volume 146,532
Open 3.740
Previous Close 3.670
Day's Range 3.390 - 3.740
52-Week Range 3.040 - 8.440
Beta 1.07
Analysts Strong Buy
Price Target 8.00 (+135.99%)
Earnings Date Mar 12, 2025

About BTMD

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice m... [Read more]

Sector Healthcare
Founded 2012
Employees 217
Stock Exchange NASDAQ
Ticker Symbol BTMD
Full Company Profile

Financial Performance

In 2024, biote's revenue was $197.19 million, an increase of 6.38% compared to the previous year's $185.36 million. Earnings were $3.16 million, a decrease of -4.79%.

Financial Statements

Analyst Forecast

According to one analyst, the rating for BTMD stock is "Strong Buy" and the 12-month stock price forecast is $8.0.

Price Target
$8.0
(135.99% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Biote Announces Purchase of Shares by Directors and CEO

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) a leading solutions provider in preventive health care through the delivery of personalized hormone optimization a...

12 days ago - Business Wire

biote Corp. (BTMD) Q4 2024 Earnings Call Transcript

biote Corp. (NASDAQ:BTMD) Q4 2024 Earnings Conference Call March 12, 2025 5:00 PM ET Corporate Participants Szymon Serowiecki - Investor Relations Mark Beard - Executive Chairman Bret Christensen - C...

18 days ago - Seeking Alpha

Biote Reports Fourth Quarter and Full Year 2024 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today a...

18 days ago - Business Wire

Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

4 weeks ago - Business Wire

Biote Announces CEO Retirement and Succession Plan

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

2 months ago - Business Wire

biote Corp. (BTMD) Q3 2024 Earnings Call Transcript

biote Corp. (NASDAQ:BTMD) Q3 2024 Earnings Call November 12, 2024 5:00 PM ET Company Participants Szymon Serowiecki - Investor Relations Terry Weber - Chief Executive Officer Bob Peterson - Chief Fin...

4 months ago - Seeking Alpha

Biote Reports Third Quarter 2024 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today a...

4 months ago - Business Wire

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

5 months ago - Business Wire

biote Corp. (BTMD) Q2 2024 Earnings Call Transcript

biote Corp. (NASDAQ:BTMD) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Szymon Serowiecki – Investor Relations Terry Weber – Chief Executive Officer Bob Peterson – C...

8 months ago - Seeking Alpha

Biote Reports Second Quarter 2024 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today a...

8 months ago - Business Wire

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

8 months ago - Business Wire

Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

10 months ago - Business Wire

biote Corp. (BTMD) Q1 2024 Earnings Call Transcript

biote Corp. (NASDAQ:BTMD) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Simon Serowiecki - Investor Relations Terry Weber - Chief Executive Officer Bob Peterson - Chief...

11 months ago - Seeking Alpha

Biote Reports First Quarter 2024 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today a...

11 months ago - Business Wire

Biote Announces Definitive Settlement with Founder

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

11 months ago - Business Wire

Biote Schedules First Quarter 2024 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

1 year ago - Business Wire

This overlooked corner of women's health could be a $350 billion market opportunity

Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey.

Other symbols: PFEPGNYVTGNDARE
1 year ago - CNBC

biote Corp. (BTMD) Q4 2023 Earnings Call Transcript

biote Corp. (BTMD) Q4 2023 Earnings Call Transcript

1 year ago - Seeking Alpha

Biote Reports Fourth Quarter and Full Year 2023 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today a...

1 year ago - Business Wire

Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

1 year ago - Business Wire

Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder's Shares

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

1 year ago - Business Wire

Biote Announces $20 Million Share Repurchase Authorization

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

1 year ago - Business Wire

Biote to Purchase Asteria Health

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

1 year ago - Business Wire

Biote Provides Preliminary 2023 Results and Initial 2024 Guidance

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

1 year ago - Business Wire

Biote Names Robert Peterson as Chief Financial Officer

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

1 year ago - Business Wire